Viatris: Shedding the Past
Executive Summary
Old drugs and a poorly-integrated infrastructure were all many saw in the last sizeable chunk of Degussa's Asta Medica drugs business. But Advent International and a new management team reckon they can transform what's now known as Viatris into a European in-licensing partner of choice.